FIELD: biochemistry.
SUBSTANCE: invention relates to an isolated antibody which specifically binds to a human tau protein, a method for production thereof, as well as to use thereof for treating a disease associated with tau protein. Also disclosed is an isolated nucleic acid encoding said antibody, as well as a host cell containing said nucleic acid. Invention also relates to a method of detecting neurofibrillar tangles, neuroypile sutures and/or dystrophic neurites, involving contacting a sample with said antibody.
EFFECT: invention provides effective treatment of diseases associated with tau protein.
51 cl, 30 tbl, 13 ex, 24 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| BISPECIFIC ANTIBODIES SPECIFICALLY BINDING TO PD1 AND LAG3 | 2018 |
|
RU2778805C2 |
| BISPECIFIC ANTIGEN-BINDING MOLECULES AND METHODS OF THEIR USE | 2019 |
|
RU2800779C2 |
| ANTIBODIES AGAINST SIGNAL-REGULATORY ALPHA PROTEIN AND THEIR APPLICATION METHODS | 2017 |
|
RU2771964C2 |
| ANTIBODIES TO DENGUE VIRUS WITH CROSS-REACTIVITY WITH ZIKA VIRUS | 2019 |
|
RU2811697C2 |
| ANTIBODIES TO DENGUE VIRUS, POLYPEPTIDES CONTAINING FC-REGION OPTIONS AND THEIR APPLICATION METHODS | 2017 |
|
RU2758596C2 |
| C5 ANTIBODIES AND THEIR APPLICATION METHODS | 2015 |
|
RU2746356C2 |
| ANTI-HLA-G ANTIBODIES AND THEIR USE | 2019 |
|
RU2797724C2 |
| ANTIBODIES AGAINST TRYPTASE, THEIR COMPOSITIONS AND APPLICATIONS | 2018 |
|
RU2771485C2 |
| ANTI-C5 ANTIBODIES AND METHODS FOR THEIR USE | 2017 |
|
RU2789788C2 |
| ANTIBODIES TO MYOSTATIN AND THEIR APPLICATION METHODS | 2017 |
|
RU2778945C2 |
